Baltimore Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Baltimore Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$534K	Buy	+4,780	New	+$524K	0.86%	36
2018 Q3	$579K	Sell	4,750 -15	-0.3%	-$1.77K	0.93%	33
2018 Q2	$523K	Sell	4,765 -235	-5%	-$25.1K	0.78%	40
2018 Q1	$534K	Sell	5,000 -460	-8%	-$51K	0.8%	36
2017 Q4	$583K	Sell	5,460 -300	-5%	-$32.1K	0.82%	39
2017 Q3	$640K	Sell	5,760 -840	-13%	-$89.8K	0.9%	38
2017 Q2	$682K	Sell	6,600 -165	-2%	-$16.3K	0.99%	36
2017 Q1	$661K	Buy	+6,765	New	+$648K	0.88%	35

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Baltimore Capital Management's IBB Position: Q1 2019 in Review

Baltimore Capital Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2019: 4,780 shares worth $534K. The stake represents 0.86% of the portfolio and ranks #36 among its holdings. This is a return to the name: Baltimore Capital Management previously reported a position in IBB as recently as Q3 2018.

Baltimore Capital Management first reported a position in IBB in Q1 2017 and has held it in 8 quarters since. The position peaked at $682K in Q2 2017. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Baltimore Capital Management held 4,780 shares of iShares Biotechnology ETF worth $534K as of Q1 2019.
iShares Biotechnology ETF was a new Baltimore Capital Management position in Q1 2019.
iShares Biotechnology ETF made up 0.86% of Baltimore Capital Management's portfolio in Q1 2019, its #36 holding.
Baltimore Capital Management first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 8 quarters since.
Baltimore Capital Management's iShares Biotechnology ETF position peaked at $682K in Q2 2017.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Baltimore Capital Management's 13F filing for Q1 2019, filed 14 May 2019.